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Introduction
Life-threatening decreases in blood pressure often are
associated with a state of shock – a condition in which tissue
perfusion is not capable of sustaining aerobic metabolism.
Shock can be produced by decreases in cardiac output
(cardiogenic), by sepsis (distributive), or by decreases in
intravascular volume (hypovolemic). The latter may be caused
by dehydration from vomiting or diarrhea, by severe
environmental fluid losses, or by rapid and substantial loss of
blood. A less common form of shock (cytopathic) may occur
when the mitochondria are incapable of producing the energy
required to sustain cellular function [1]. Agents that interfere
with oxidative phosphorylation, such as cyanide, carbon
monoxide and rotenone, can produce this type of shock.
Hemorrhage is a medical emergency that is frequently
encountered by physicians in emergency rooms, operating
rooms, and intensive care units. Significant loss of intra-
vascular volume may lead sequentially to hemodynamic
instability, decreased tissue perfusion, cellular hypoxia, organ
damage, and death. This review addresses the patho-
physiology and treatment of hypovolemic shock produced by
hemorrhage, which is also known as hemorrhagic shock.
Physiologic considerations in hemorrhagic
shock
Estimating blood loss
The average adult blood volume represents 7% of body
weight (or 70 ml/kg of body weight) [2]. Estimated blood
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Abstract
This review addresses the pathophysiology and treatment of hemorrhagic shock – a condition
produced by rapid and significant loss of intravascular volume, which may lead sequentially to
hemodynamic instability, decreases in oxygen delivery, decreased tissue perfusion, cellular hypoxia,
organ damage, and death. Hemorrhagic shock can be rapidly fatal. The primary goals are to stop the
bleeding and to restore circulating blood volume. Resuscitation may well depend on the estimated
severity of hemorrhage. It now appears that patients with moderate hypotension from bleeding may
benefit by delaying massive fluid resuscitation until they reach a definitive care facility. On the other
hand, the use of intravenous fluids, crystalloids or colloids, and blood products can be life saving in
those patients who are in severe hemorrhagic shock. The optimal method of resuscitation has not been
clearly established. A hemoglobin level of 7–8 g/dl appears to be an appropriate threshold for
transfusion in critically ill patients with no evidence of tissue hypoxia. However, maintaining a higher
hemoglobin level of 10 g/dl is a reasonable goal in actively bleeding patients, the elderly, or individuals
who are at risk for myocardial infarction. Moreover, hemoglobin concentration should not be the only
therapeutic guide in actively bleeding patients. Instead, therapy should be aimed at restoring
intravascular volume and adequate hemodynamic parameters.
Keywords blood loss, estimated blood volume, hemorrhage, oxygen consumption, oxygen delivery, shock, transfusion
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volume (EBV) for a 70 kg person is approximately 5 l. Blood
volume varies with age and physiologic state. When indexed
to body weight, older individuals have a smaller blood
volume. Children have EBVs of 8–9% of body weight, with
infants having an EBV as high as 9–10% of their total body
weight [3].
Estimating blood loss is complicated by several factors,
including urinary losses and the development of tissue
edema. To help guide volume replacement, hemorrhage can
be divided into four classes (Table 1). Class I is a nonshock
state, such as occurs when donating a unit of blood, whereas
class IV is a preterminal event requiring immediate therapy [4].
Massive hemorrhage may be defined as loss of total EBV within
a 24-hour period, or loss of half of the EBV in a 3-hour period.
A relatively simple way to estimate acute blood loss is by
considering the intravascular space as a single compartment,
in which hemoglobin changes according to the degree of
blood loss and fluid replacement (Fig. 1). When volume
losses are not replaced during hemorrhage, hemoglobin
concentration will remain constant. In that condition a rough
estimate of blood loss may be obtained using the
classification provided in Table 1. Conversely, when blood
losses are sequentially replaced by isovolemic fluid infusion,
the estimated blood loss may be obtained as follows [5]:
EBL = EBV × ln(Hi/Hf)
Where Hi and Hf denote the initial and final hematocrit.
Implicit in this equation is the absence of significant urinary
losses or the leakage of intravascular fluid into the tissues.
For example, a decrease in hematocrit from 40% to 26% with
complete fluid replacement of blood losses corresponds to
an estimated blood loss of 2.1 l.
Intravenous fluid infusion in the absence of bleeding also will
lower hemoglobin concentration. Using the one-compartment
model, a first approximation to hemodilution with intravenous
fluids is as follows:
Hf = EBV × Hi/(EBV + volume infused)
This is the lowest possible estimate of Hf, because fluid
administration and expansion of intravascular fluid volume will
trigger compensatory mechanisms to increase glomerular
filtration rate and decrease plasma volume.
Transfusing packed red cells in a person who is not actively
bleeding will increase hemoglobin concentration by 1 g/dl (or
3% hematocrit) per unit of packed red blood cell transfused.
It is impossible to estimate the effect of blood transfusion on
volume or hemoglobin concentration in actively bleeding
individuals. Measures of central venous or, preferably,
Table 1
Classification of hemorrhage
Class
Parameter I II III IV
Blood loss (ml) <750 750–1500 1500–2000 >2000
Blood loss (%) <15% 15–30% 30–40% >40%
Pulse rate (beats/min) <100 >100 >120 >140
Blood pressure Normal Decreased Decreased Decreased
Respiratory rate (breaths/min) 14–20 20–30 30–40 >35
Urine output (ml/hour) >30 20–30 5–15 Negligible
CNS symptoms Normal Anxious Confused Lethargic
Modified from Committee on Trauma [4]. CNS = central nervous system.
Figure 1
One compartment model of the vascular space.
Intravascular
space
Tissue
leakage
Fluid replacement
Blood loss
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pulmonary artery pressures are needed to estimate the
degree of fluid replacement that may be required.
Alterations in systemic oxygen delivery during
hemorrhagic shock
Decreases in circulating blood volume during severe
hemorrhage can depress cardiac output and lower organ
perfusion pressure. Severe hemorrhage impairs the delivery
of oxygen and nutrients to the tissues and produces a state of
shock. A clearer understanding of the pathophysiology of
hemorrhagic shock may be obtained by defining the process
of oxygen delivery and utilization by the tissues. Total oxygen
delivery (DO2 [mlO2/min per m2]) is the product of cardiac
index (l/min per m2) and arterial oxygen content (CaO2 [mlO2/l
blood]). CaO2 is calculated as 13.4 × [Hb] × SaO2 + 0.03 PaO2,
where [Hb] represents the concentration of hemoglobin in
blood (g/dl), SaO2 is the hemoglobin oxygen saturation and
PaO2 is the partial pressure of oxygen in arterial blood.
Under normal aerobic conditions, systemic oxygen consumption
(VO2) is proportional to the metabolic rate and varies
according to the body’s energy needs. VO2 may be calculated
using Fick’s principle as the difference between the rates of
oxygen delivered and oxygen leaving the tissues: VO2 =
cardiac index × (CaO2 – CmvO2), where CmvO2 is the oxygen
content of mixed venous blood. Calculation of VO2 using Fick’s
equation does not account for pulmonary oxygen consumption,
which may be substantial during acute lung injury [6].
Another useful parameter when defining tissue oxygenation is
the fraction of oxygen consumed to oxygen delivered to the
tissues, termed the oxygen extraction ratio and calculated as
(CaO2 – CmvO2)/CaO2.
The relationship of oxygen delivery to oxygen
consumption during hemorrhagic shock
Rapid decreases in blood volume may lead to decreases in
cardiac output and in DO2 with little change in VO2, because
blood flow is preferentially distributed to tissues with greater
metabolic requirements. Increased efficiency in oxygen
utilization during hypoxia is reflected by a rise in oxygen
extraction ratio [7]. Lowering regional vascular resistance by
adenosine, prostaglandins, and nitric oxide induces hypoxic
redistribution of blood flow [8,9]. In spite of this organ-
specific microvascular response, all organs, with the possible
exception of the heart, experience decreases in blood flow
during severe hypovolemia [10].
Another targeted response to hemorrhage is an increase in
the number of open capillaries in organs that are capable of
this. For example, in skeletal muscle only a fraction of
capillaries are usually open to accommodate the passage of
erythrocytes whereas the remaining capillaries allow only
passage of plasma [11]. During hemorrhage the number of
open capillaries increases in proportion to the degree of
tissue hypoxia [12]. Capillary recruitment shortens the
diffusion distance from red blood cells to the surrounding
tissue [13] and increases the capillary surface area available
for oxygen diffusion [14]. The overall effect of capillary
recruitment is the maintenance of tissue oxygen flux at a
lower capillary oxygen tension, which is a vital response in
organs on the edge of hypoxia.
Severe and sustained decreases in DO2 eventually overwhelm
the microvascular responses to hypoxia. As tissue oxygen flux
falters, mitochondria cannot sustain aerobic metabolism and
VO2 decreases. The rate of DO2 associated with the initial
decline in VO2 is defined as the critical DO2 (DO2crit) [15].
Animal experiments show that DO2crit is a remarkably constant
parameter regardless of the method used to decrease DO2,
be it anemia, hypoxemia, or hypovolemia [16].
Hypovolemia and isovolemic anemia
Patients with massive hemorrhage may experience conditions
ranging from severe hypovolemia, in which blood volume
decreases with no changes in hemoglobin concentration, to
isovolemic anemia, in which extreme decreases in hemo-
globin concentration occur with normal or even increased
blood volume.
Hypovolemia occurs in rapidly bleeding individuals who are
not receiving intravenous fluids. The importance of circulating
blood volume has been demonstrated in animals subjected to
the sequential removal of blood aliquots from a central vein
[17]. These experiments show that VO2 remains constant as
the circulating blood volume decreases. VO2 falls
precipitously and death rapidly ensues below a DO2crit of
8–10 mlO2/min per kg. At this critical juncture, decreases in
blood volume approach 50% with no changes in hemoglobin
concentration. Hypovolemia is associated with substantial
decreases in cardiac output and mixed venous oxygen tension.
Aggressive fluid replacement may produce the condition of
isovolemic anemia, which is characterized by adequate blood
volume but decreased hemoglobin concentration and low
oxygen carrying capacity. Isovolemic anemia occurs when
blood for transfusion is not readily available or in individuals
who are bleeding but refuse to accept blood products.
Experimental isovolemic anemia is produced by drawing
blood aliquots from a central vein and replacing the exact
amount of blood removed with a colloidal solution such as
albumin. Animals subjected to progressive isovolemic anemia
also exhibit a DO2crit in the neighborhood of 10 mlO2/min per kg
[18]. DO2crit is reached at a hemoglobin concentration of
approximately 4.0 g/dl (corresponding to a hematocrit <8%).
Isovolemic anemia is associated with increased cardiac
output and greater mixed venous oxygen tensions than those
noted for hypovolemia or hypoxemia [19].
Individuals with chronic isovolemic anemia, such as those
with renal failure, tolerate decreases in hemoglobin to levels
of 6–7 g/dl. In fact, acute hemodilution did not produce
Available online http://ccforum.com/content/8/5/373
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tissue hypoxia in healthy human volunteers who had their
blood hemoglobin concentration reduced to 5.0 g/dl [20].
Acute isovolemic hemodilution decreased systemic vascular
resistance and increased heart rate, stroke volume, and
cardiac index, but there were no changes in VO2 or in plasma
lactate. In a subsequent study conducted in resting volunteers,
hemoglobin concentration was lowered by isovolemic anemia
to 4.8 g/dl, decreasing DO2 to 7.3 mlO2/min per kg without
evidence of inadequate systemic oxygenation [21].
Cellular responses to acute blood loss
Compensated shock occurs when systemic DO2 decreases
below DO2crit and the tissues turn to anaerobic sources of
energy. Under these conditions, cellular function is
maintained as long as the combined yield of aerobic and
anaerobic sources of energy provides sufficient ATP for
protein synthesis and contractile processes. Some tissues
are more resistant to hypoxia than others. Skeletal and
smooth muscles are highly resistant to hypoxia [22,23] and
irreversible damage does not occur in isolated hepatocytes
until 2.5 hours of ischemia [24]. Conversely, brain cells
sustain permanent damage after only a few minutes of
hypoxia [25]. The gut appears to be particularly sensitive to
decreases in perfusion. The intestinal and gastric mucosa
show evidence of anaerobic metabolism before decreases in
systemic VO2 are detected [26].
Uncompensated shock resulting in irreversible tissue damage
occurs when the combined aerobic and anaerobic supplies
of ATP are not sufficient to maintain cellular function (Fig. 2).
Failure of membrane-associated ion transport pumps, in
particular those associated with the regulation of calcium and
sodium, results in the loss of membrane integrity and in
cellular swelling [27,28]. Among other mechanisms that lead
to irreversible cellular injury during hypoxia are depletion of
cellular energy, cellular acidosis, oxygen free radical
generation, and loss of adenine nucleotides from the cell [29].
Systemic responses to acute blood loss
The first response to blood loss is an attempt to form a clot at
the local site of hemorrhage. As hemorrhage progresses,
catecholamines, antidiuretic hormone, and atrial natriuretic
receptors respond to the perceived loss of volume by
vasoconstriction of arterioles and muscular arteries and by
increasing the heart rate. The aim of these compensatory
mechanisms is to increase cardiac output and maintain
perfusion pressure. Urine output drops somewhat and thirst
is stimulated to maintain circulating blood volume.
Anxiety may be related to the release of catecholamines and
to mild decreases in cerebral blood flow. A person who is
bleeding briskly also may develop tachypnea and hypo-
tension. As hypovolemia worsens and tissue hypoxia ensues,
increases in ventilation compensate for the metabolic acidosis
produced by increased carbon dioxide production. Compen-
satory mechanisms are eventually overwhelmed by volume
losses, and blood flow to the renal and splanchnic vasculature
decreases and systolic blood pressure declines. The loss of
coronary perfusion pressure adversely affects myocardial
contractility; cerebral blood flow decreases, resulting in the
loss of consciousness, coma, and eventually death.
Clinical considerations in hemorrhagic shock
The therapeutic goals for hemorrhagic shock are to stop
bleeding and to restore intravascular volume. This review
does not address methods of stopping hemorrhage, but rather
deals with the physiologic and pathologic derangements
produced by severe hemorrhage and how best to treat them.
Clinical manifestations
Shock is a state of hypoperfusion associated with hemo-
dynamic abnormalities leading to the collapse of homeo-
stasis, or as poetically stated by John Collins Warren, a
‘momentary pause in the act of death’ [30]. The etiology of
shock in traumatized patients is likely to be massive blood
loss but other causes of shock must be considered. These
include blunt myocardial damage, spinal cord injury, tension
pneumothorax, or pericardial tamponade.
Not all trauma patients with tissue hypoperfusion as the result
of massive hemorrhage arrive at the emergency department
with signs of shock. The lack of a specific diagnosis should
not delay resuscitation from severe hypovolemia when hemor-
rhage is suggested by history, physical examination, or
laboratory findings.
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Figure 2
Changes in oxygen consumption shown as a function of oxygen
delivery. Also shown are the hypothetical relationships of these
parameters to the stages of hemorrhage (Table 1) and changes in
cellular membrane integrity. DO2crit, critical oxygen delivery.
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A rapid assessment of the possible source of bleeding is
essential when acute hemorrhage is the suspected cause for
hemodynamic instability, and a thorough physical examination
should be performed. Emergency personnel may give an
estimate of blood loss at the scene, but one should always be
wary of such estimates because they are notoriously
inaccurate. In general, young patients who present with
tachycardia and mild hypotension are in danger of losing their
compensatory mechanisms and may well slip into profound
shock unless vigorous therapy is initiated. Reliance on
systolic blood pressure alone may delay recognition of the
shock state. Most practitioners can palpate a carotid pulse in
an adult. This is equivalent to a systolic pressure of
60 mmHg. A femoral pulse is produced by a systolic pressure
of 60–70 mmHg. A palpable radial pulse usually requires
slightly higher pressures.
Gastrointestinal bleeding and trauma are the most common
causes of hemorrhage. Other causes of hemorrhagic shock
include ruptured abdominal aortic aneurysms, spontaneous
bleeding from anticoagulation, and postpartum bleeding
secondary to a placenta previa or placenta abruption
(Table 2). A ruptured ectopic pregnancy or a ruptured ovarian
cyst also can cause hemorrhagic shock without an obvious
source of blood loss [31]. The evaluation of shock in a
woman of childbearing age should include a pregnancy test
and possibly a culdocentesis. Stopping the bleeding, as well
as replacing the blood volume, is the treatment for shock
resulting from postpartum hemorrhage.
Blood losses from external lacerations are difficult to
estimate but usually respond to direct pressure and volume
resuscitation. Intrathoracic injuries, especially to the lung,
heart, or the great vessels, can result in the loss of several
liters of blood into the thorax without external evidence of
hemorrhage. Intra-abdominal injuries to solid organs (spleen
and liver) and great vessels (ruptured aneurysm, penetrating
injury to intra-abdominal vessels) can cause rapid loss of the
entire blood volume into the abdomen. Massive bleeding into
the gastrointestinal tract from ulcers or intestinal diverticuli
can likewise cause shock, but the patient usually manifests
either hematochezia or hematemesis when blood loss is
rapid and acute.
Fractures of the pelvis can hide massive amounts of bleeding
with little external evidence [32]. An unstable pelvis on
physical examination always raises the possibility of
significant blood loss. Spontaneous bleeding into the
retroperitoneum can also cause shock without significant
physical findings. Fractures of the lower extremities,
especially closed femur fractures, can easily hide 2–3 units of
blood, whereas open fractures can lacerate major vessels
and cause significant blood loss. Head injury is rarely a cause
of hypotension and is never the cause of massive blood loss,
unless there is external bleeding.
Treatment of hemorrhagic shock
The main goals of resuscitation are to stop the source of
hemorrhage and to restore circulating blood volume. Actively
bleeding patients should have their intravascular fluid
replaced because tissue oxygenation will not be compro-
mised, even at low hemoglobin concentrations, as long as
circulating volume is maintained. Hemoglobin concentration
in an actively bleeding individual has dubious diagnostic value
because it takes time for the various intravascular compart-
ments to equilibrate. Rather, therapy should be guided by the
rate of bleeding and changes in hemodynamic parameters,
such as blood pressure, heart rate, cardiac output, central
venous pressure, pulmonary artery wedge pressure, and
mixed venous saturation.
Restoration of the intravascular fluid volume
Since the time of World War II, the accepted therapeutic
dogma has been to restore blood volume rapidly and achieve
Available online http://ccforum.com/content/8/5/373
Table 2
Common causes of hemorrhagic shock
Cause Examples (where applicable)
Antithrombotic therapy
Coagulopathies
Gastrointestinal bleeding Esophageal varices
Esophagogastric mucosal tear 
(Mallory–Weiss)
Gastritis
Gastric and duodenal ulcerations
Gastric and esophageal cancer
Colon cancer
Colonic diverticula
Obstetric/gynecologic Placenta previa
Abruptio placentae
Ruptured ectopic pregnancy
Ruptured ovarian cyst
Pulmonary Pulmonary embolus
Lung cancer
Cavitary lung disease: 
tuberculosis, aspergillosis
Goodpasture’s syndrome
Ruptured aneurysms
Retroperitoneal bleeding
Trauma Lacerations
Penetrating wounds to the 
abdomen and chest
Ruptured major vessels
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normal physiologic parameters. Generations of physicians
have been trained to reverse shock within the ‘golden hour’ in
order to preserve organ function and prevent death.
As early as 1918, however, Cannon and coworkers [33]
questioned the feasibility of restoring blood pressure back to
normal in the face of active hemorrhage. Wiggers [34]
proposed the concept of ‘irreversible shock’ after showing
that reinfusing blood into a profoundly shocked animal was
not sufficient to prevent mortality and morbidity. Subse-
quently, Shires and coworkers [35] demonstrated in experi-
mental preparations that crystalloid fluids were needed in
addition to blood to restore perfusion. They were able to
demonstrate failure of the sodium–potassium pump, resulting
in the ingress of sodium and water into the cells. The
awareness of ‘third space losses’ into the interstitium and
tissues resulted in the ‘three-to-one’ rule for resuscitation:
that is, 3 ml of crystalloid (Ringers lactate or normal saline) for
every 1 ml of blood loss replaced.
Four issues should be considered when treating hemorrhagic
shock: type of fluid to give, how much, how fast, and what the
therapeutic end-points are. The ideal fluid for resuscitation
has not been established. The three-to-one rule has been
applied to the classification of hemorrhage to establish a
baseline for guiding therapy [36], and use of crystalloid
(Ringers lactate or normal saline) is recommended by the
American College of Surgeons [4]. Although resuscitative
end-points are similar when using Ringers lactate or normal
saline, metabolic hyperchloremic acidosis has been reported
when infusing large volumes of normal saline (>10 l) [35].
Colloidal solutions, such as albumin and hetastarch (6%
hydroxyethyl starch in 0.9% NaCl), can be administered to
increase circulatory volume rapidly. Although it is beyond the
scope of this review to enter the crystalloid versus colloid
fray, we should note that the use of albumin solutions in the
initial resuscitation stages has not proven to be more
effective than crystalloid [37–39]. A meta-analysis of 26
prospective randomized trials (including a total of 1622
patients) revealed an increased absolute risk for death of 4%
when colloids were used for resuscitation [40]. The results of
this meta-analysis sparked a great deal of controversy on the
use of albumin as a replacement fluid. The conclusions of
these analyses should be viewed with caution because the
inclusion criteria for the various studies included in the meta-
analyses differed. It should be noted, however, that the
American College of Surgeons does recommend the use of
albumin as a resuscitative fluid [4].
Hypertonic saline
There is continuing interest in the role of hypertonic saline
during resuscitation from hypovolemic shock. There is some
evidence that the use of hypertonic saline in traumatized
patients with closed head injury may be efficacious [41], but
this is controversial and the US Food and Drug
Administration has not given approval for its use during the
resuscitation of patients. A prospective, randomized study
comparing hypertonic saline with dextran found no difference
in survival between the hypertonic saline group and the
dextran-treated group [42]. Small volume hypertonic saline
does hold some promise in cases of penetrating trauma [43].
Blood substitutes
Blood substitutes have been tried in many forms [44]. A
report by Gould and colleagues [45] on the effect of massive
doses of hemoglobin solutions in hemorrhagic trauma patients
demonstrated a possible benefit when compared with
infusion of crystalloids. In that study, 171 patients received
rapid infusion of 1–20 units of poly-HEME (Sigma, St. Louis,
MO, USA; human polymerized hemoglobin) in lieu of human
blood. Mortality was 25%, as compared with 64% for
historical matched control individuals. On the other hand, the
sobering results of a randomized, prospective, multicenter
study conducted by Sloan and coworkers [46], in which
traumatic hemorrhagic shock patients were treated with
diaspirin cross-linked hemoglobin, will remain an impediment
to further research in this area for many years to come. At
28 days, 24 (46%) of the 52 patients infused with diaspirin
cross-linked hemoglobin died compared with eight (17%) of
the 46 patients infused with a saline solution (P = 0.003).
When to transfuse
The use of blood and blood products is necessary when the
estimated blood loss from hemorrhage exceeds 30% of the
blood volume (class III hemorrhage). Determining this point
has been extremely difficult during an acute hemorrhage
because of hemodilution produced by fluid resuscitation. As
mentioned previously, whereas formulas have been proposed
to estimate blood losses, the use of blood as a resuscitative
fluid is empirical [5,47].
Presently, a hypotensive patient who fails to respond to 2 l
crystalloid in the face of probable hemorrhage should be
treated with blood and blood products. O-negative blood for
women and O-positive for men is infused if type and cross-
matched blood is not easily available. Blood transfusions
have several negative side effects and have been associated
with worse outcome in patients with trauma [48]. Among the
complications of blood transfusion are decreased immunity
and increased rate of infection, as well as problems
associated with transmissible diseases and improper
administration [49,50].
Transfusion in the critically ill patient
Several national organizations in the USA and Canada have
issued guidelines for blood transfusion. These include the
consensus conferences of the National Institutes of Health
[51], the American College of Physicians [52], the American
Society of Anesthesiology [53], and the Canadian Medical
Association [54]. These guidelines recommend a hemoglobin
level between 6 and 8 g/dl as a threshold for transfusion in
Critical Care    October 2004 Vol 8 No 5 Gutierrez et al.
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patients without known risk factors. They also agree in their
disapproval of prophylactic blood transfusion, because patients
with hemoglobin levels greater than 10 g/dl are unlikely to
benefit from blood transfusion. These guidelines have rapidly
been incorporated into the everyday practice of medicine,
leading some to question whether blood transfusion is now
under-used [55].
When it comes to high risk or critically ill patients, clinical
evidence in support of transfusion guidelines is more difficult to
obtain and therapy has often been guided by clinical judgment.
A study of transfusion practices in Canada noted that 28% of
patients admitted to tertiary level intensive care units received
red cell transfusions [56]. The most frequent reason for
administering red cells was not the patient’s hemoglobin
concentration. Instead, blood transfusions were ordered if
patients were acutely bleeding (35% of patients transfused) or
in order to increase DO2 (25% of patients transfused).
A multi-institutional, prospective, randomized study was
conducted to determine whether a restrictive strategy of red
cell transfusion and a liberal strategy produced equivalent
results in critically ill patients [57]. Patients were enrolled in
the study within 72 hours of admission to the intensive care
unit if their hemoglobin concentrations was below 9 g/dl.
Patients were randomly assigned either to a liberal strategy of
transfusion (n = 420), in which hemoglobin values were main-
tained at a level between 10 and 12 g/dl, or to a restrictive
strategy of transfusion, in which hemoglobin values were
maintained between 7 and 9 g/dl (n = 418). Mortality at
30 days was similar for the two groups (19% versus 23%).
Subgroup analysis showed that mortality rates were lower
with the restrictive transfusion strategy among less acutely ill
patients and among those under 55 years old. Furthermore,
the mortality rate during hospitalization was significantly lower
in the restrictive strategy group (22% versus 28%). These
data suggest that a restrictive strategy of red cell transfusion
in critically ill patients is at least as effective as a liberal
transfusion strategy. Moreover, a prospective observational
study of 1136 patients conducted in Europe showed an
association between transfusions and decreased organ
function and increased mortality [58].
Transfusion in elderly patients
Tolerance of anemia is dependent on the recruitment of
physiologic reserve, mainly by increasing cardiac output. Low
levels of hemoglobin that are tolerated by younger patients
may be deleterious in the elderly. Reserve mechanisms in the
elderly may be blunted with advanced age and the presence
of coronary artery stenosis. This also may explain why elderly
patients with acute myocardial infarction are at extremely high
risk for death despite having infarct sizes similar to those in
younger patients.
A study conducted by Wu and coworkers [59] indicated that
a substantial number of people who present to the hospital
with acute myocardial infarction and a hematocrit of 24% or
lower may benefit from blood transfusion. In a retrospective
analysis of data from 78,974 patients aged 65 years or older
and who were hospitalized with acute myocardial infarction,
those with lower hematocrit values (<24%) on admission had
higher 30-day mortality rates. Blood transfusion was asso-
ciated with a reduction in 30-day mortality among patients
whose hematocrit on admission was in the 5–24% range.
Blood transfusion did not improve survival among those
whose hematocrit values fell in the higher ranges.
Delayed versus immediate resuscitation
Recent data question the practice of initial aggressive
resuscitation of hemorrhagic shock. Cannon and coworkers
[33] raised the concern that raising blood pressure in a
bleeding patient would eliminate the clot and increase
bleeding. This theory was replaced in World War II and in
Vietnam by the concept that restoration of blood volume as
soon as possible was the key to survival. The concept of the
‘golden hour’ as the time period allowed for medical personnel
to reverse shock and prevent organ system damage has
dominated the thinking of trauma surgeons for a generation.
Bickell and coworkers [60] challenged this approach when
they performed a randomized prospective study of patients
with penetrating truncal injuries who were hypotensive in the
field (systolic blood pressure <90 mmHg). Patients were
randomized according to the day of the month to receive
either standard resuscitation with Ringers lactate or place-
ment of intravenous catheters without intravenous fluid admini-
stration. Patients were excluded if they had cardiopulmonary
collapse in the field, severe head injury, or did not need
surgical intervention. A total of 598 matched control patients
were included in the study group. The immediate resusci-
tation group received an average of 900 ml fluid before
hospitalization compared with 100 ml fluid in the delayed
resuscitation group. Of the delayed resuscitation group 70%
were discharged, as compared with 62% of the immediate
fluid group (P = 0.04), and the delayed group trended to have
fewer complications.
Animal data demonstrate a reduced risk for death with fluid
resuscitation in severe hemorrhage. On the other hand, a
systematic review of the animal studies also showed an
increased risk for death from aggressive resuscitation in animals
with less severe hemorrhage [61]. This finding suggests that
excessive fluid resuscitation can be lethal when severe
hemorrhage is not present. Another study [62] found no
differences in survival in patients presenting in hemorrhagic
shock treated with two fluid replacement protocols, one that
required fluid replacement to a systolic blood pressure in excess
of 100 mmHg (conventional) and another that required fluid
replacement to a systolic blood pressure in excess of 70 mmHg.
Whether or not one fully resuscitates a bleeding patient
depends on the rate of bleeding, the ability to control the
Available online http://ccforum.com/content/8/5/373
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bleeding, and the presence of coagulopathy. It may be that
excessive fluid resuscitation before surgical hemostasis will
be accompanied by increased bleeding that may ultimately
affect mortality. Although some actively bleeding patients will
exsanguinate immediately, others will stop bleeding
spontaneously. Fluid resuscitation should be focused on
injuries that will not undergo spontaneous hemostasis [63].
The challenge lies in identifying those patients.
End-points in resuscitation
Defining the end-points of resuscitation is also a difficult area
of study. Up to 85% of patients are under-resuscitated when
using blood pressure and urine output as the sole guides to
fluid replacement [64]. The problem may be ‘compensated
shock’, in which cellular perfusion lags behind gross
physiologic parameters. Other end-points, such as oxygen
transport variables, DO2, cardiac index, VO2, lactate, base
deficit, and mucosal gastric pH, are all more sensitive end-
points of cellular resuscitation [65]. Recent data on tissue
oxygen parameters also suggest that these measures are
promising markers of adequate restoration of perfusion [66].
The use of super normal delivery of oxygen has been
proposed but a study conducted by McKinley and coworkers
[67] demonstrated that levels of DO2 greater than 600 ml/min
per m2 are not warranted.
Conclusion
Hemorrhagic shock can be rapidly fatal. The primary goal is to
stop the bleeding. Resuscitation may well depend on
estimated severity of hemorrhage. It now appears that patients
who have moderate hypotension from moderate bleeding may
well benefit from a delay in massive resuscitation in order to
reach a definitive care facility. On the other hand, when
patients are obviously in severe hemorrhagic shock, the use of
intravenous crystalloids or colloids and blood products when
available can be life saving. Uncertainties remain regarding the
best method for resuscitation, what type of fluid, how much,
when, and how fast [68].
A hemoglobin level of 7–8 g/dl is an appropriate threshold for
transfusion in critically ill patients with no risk factors for
tissue hypoxia. Maintaining a hemoglobin level of 10 g/dl is a
reasonable goal for patients who are actively bleeding, the
elderly, or individuals at risk for a myocardial infarction.
Moreover, hemoglobin concentration should not be the only
therapeutic guide in actively bleeding patients. Instead,
therapy should be aimed at restoring intravascular volume
and adequate hemodynamic parameters.
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